Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Defining and targeting transcription factors in cancer.

Redmond AM, Carroll JS.

Genome Biol. 2009;10(7):311. doi: 10.1186/gb-2009-10-7-311. Epub 2009 Jul 24.

PMID:
19664186
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The ying-yang of RAR and AP-1: cancer treatment without overt toxicity.

Allenby G.

Hum Exp Toxicol. 1995 Feb;14(2):226-30. Review. No abstract available.

PMID:
7779452
[PubMed - indexed for MEDLINE]
3.

Tackling transcription factors: challenges in antitumor therapy.

Grivas PD, Kiaris H, Papavassiliou AG.

Trends Mol Med. 2011 Oct;17(10):537-8. doi: 10.1016/j.molmed.2011.06.005. Epub 2011 Jul 19. No abstract available.

PMID:
21775208
[PubMed - indexed for MEDLINE]
4.

Polycomb group proteins: navigators of lineage pathways led astray in cancer.

Bracken AP, Helin K.

Nat Rev Cancer. 2009 Nov;9(11):773-84. doi: 10.1038/nrc2736. Review.

PMID:
19851313
[PubMed - indexed for MEDLINE]
5.

Oncogenes as novel targets for cancer therapy (part III): transcription factors.

Zhang Z, Li M, Rayburn ER, Hill DL, Zhang R, Wang H.

Am J Pharmacogenomics. 2005;5(5):327-38. Review.

PMID:
16196502
[PubMed - indexed for MEDLINE]
6.

HIFing the brakes: therapeutic opportunities for treatment of human malignancies.

Garcia JA.

Sci STKE. 2006 May 30;2006(337):pe25. Review.

PMID:
16738063
[PubMed - indexed for MEDLINE]
7.

The role of Snf2-related proteins in cancer.

Owen-Hughes T.

Ernst Schering Res Found Workshop. 2006;(57):47-59. Review.

PMID:
16568948
[PubMed - indexed for MEDLINE]
8.

Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.

Firlej V, Ladam F, Brysbaert G, Dumont P, Fuks F, de Launoit Y, Benecke A, Chotteau-Lelievre A.

J Cell Sci. 2008 Oct 15;121(Pt 20):3393-402. doi: 10.1242/jcs.027201. Epub 2008 Sep 30.

PMID:
18827017
[PubMed - indexed for MEDLINE]
Free Article
9.

Transcription factors as drug targets in cancer.

Hurst HC.

Eur J Cancer. 1996 Oct;32A(11):1857-63. Review.

PMID:
8943667
[PubMed - indexed for MEDLINE]
10.

Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells.

Johnson PH, Walker RP, Jones SW, Stephens K, Meurer J, Zajchowski DA, Luke MM, Eeckman F, Tan Y, Wong L, Parry G, Morgan TK Jr, McCarrick MA, Monforte J.

Mol Cancer Ther. 2002 Dec;1(14):1293-304.

PMID:
12516962
[PubMed - indexed for MEDLINE]
Free Article
11.

Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer.

Seville LL, Shah N, Westwell AD, Chan WC.

Curr Cancer Drug Targets. 2005 May;5(3):159-70. Review.

PMID:
15892617
[PubMed - indexed for MEDLINE]
12.

Mining for regulatory programs in the cancer transcriptome.

Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM.

Nat Genet. 2005 Jun;37(6):579-83.

PMID:
15920519
[PubMed - indexed for MEDLINE]
13.

The DNA methylation machinery as a target for anticancer therapy.

Szyf M.

Pharmacol Ther. 1996;70(1):1-37. Review.

PMID:
8804109
[PubMed - indexed for MEDLINE]
14.

CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.

Cho-Chung YS.

Antisense Nucleic Acid Drug Dev. 1998 Apr;8(2):167-70. Review. No abstract available.

PMID:
9593058
[PubMed - indexed for MEDLINE]
15.

Cancerous miRNAs and their regulation.

Shi XB, Tepper CG, deVere White RW.

Cell Cycle. 2008 Jun 1;7(11):1529-38. Epub 2008 Mar 20. Review.

PMID:
18469525
[PubMed - indexed for MEDLINE]
Free Article
16.

Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).

Blum R, Elkon R, Yaari S, Zundelevich A, Jacob-Hirsch J, Rechavi G, Shamir R, Kloog Y.

Cancer Res. 2007 Apr 1;67(7):3320-8.

PMID:
17409441
[PubMed - indexed for MEDLINE]
Free Article
17.

From correlation to causality: microarrays, cancer, and cancer treatment.

O'Neill GM, Catchpoole DR, Golemis EA.

Biotechniques. 2003 Mar;Suppl:64-71. Review. No abstract available.

PMID:
12664688
[PubMed - indexed for MEDLINE]
18.

Use of transcription factors as agents and targets for drug development.

Smith LM, Birrer MJ.

Oncology (Williston Park). 1996 Oct;10(10):1532-8; discussion 1541-2. Review.

PMID:
8905845
[PubMed - indexed for MEDLINE]
Free Article
19.

The Myc oncoprotein as a therapeutic target for human cancer.

Vita M, Henriksson M.

Semin Cancer Biol. 2006 Aug;16(4):318-30. Epub 2006 Aug 3. Review.

PMID:
16934487
[PubMed - indexed for MEDLINE]
20.

How to overcome (and exploit) tumor hypoxia for targeted gene therapy.

Greco O, Marples B, Joiner MC, Scott SD.

J Cell Physiol. 2003 Dec;197(3):312-25. Review.

PMID:
14566961
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk